For decades clinicians, have been frustrated by the inability to successfully detoxify opiate addicted patients because opiate-based detoxification, one of the most effective means to achieving that goal, has been unavailable outside the very restrictive confines of narcotic treatment programs. Bup/Nx shows promise as an effective aid for opiate detoxification; however, little data have been generated for the shorter-term use of Bup/Nx for this indication. Because the diversity of clinics in the CTN provides an unparalleled opportunity to conduct such a clinical endeavor, the utility of buprenorphine/naloxone in short term (13 day) detoxification versus clonidine in an outpatient setting was tested in the CTN.
Principal Investigator(s)
Walter Ling, M.D.
Director
Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Boulevard
Suite 200
Los Angeles, CA 90025
lwalter@ucla.edu
Participating Sites
- Aegis Medical Systems, Inc., California
- Robert Wood Johnson University Hospital, New Jersey
- Addiction Research and Treatment Corporation, New York
- Bellevue Hospital Center, New York
- Midtown Community Mental Health Center (under Health & Hospital Corporation of Marion County), Ohio
- Kaiser Permanente, Department of Addiction Medicine